Legacy Capital Group California’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
6,006
+46
+0.8% +$10.7K 0.46% 52
2026
Q1
$1.46M Sell
5,960
-3,893
-40% -$907K 0.55% 31
2025
Q4
$2.04M Buy
9,853
+1,437
+17% +$284K 0.49% 40
2025
Q3
$1.56M Sell
8,416
-5,229
-38% -$896K 0.4% 52
2025
Q2
$2.08M Sell
13,645
-160
-1% -$24.6K 0.58% 27
2025
Q1
$2.29M Buy
13,805
+239
+2% +$37.4K 0.8% 18
2024
Q4
$1.96M Buy
13,566
+154
+1% +$23.9K 0.6% 25
2024
Q3
$2.17M Buy
13,412
+142
+1% +$22.6K 0.72% 20
2024
Q2
$1.94M Buy
13,270
+6,659
+101% +$990K 0.7% 25
2024
Q1
$1.05M Buy
6,611
+4
+0.1% +$637 0.39% 68
2023
Q4
$1.04M Buy
6,607
+200
+3% +$30.7K 0.4% 60
2023
Q3
$998K Buy
6,407
+152
+2% +$25.1K 0.43% 58
2023
Q2
$1.04M Buy
6,255
+971
+18% +$157K 0.43% 49
2023
Q1
$819K Buy
+5,284
New +$853K 0.4% 67

Other funds holding JNJ

Legacy Capital Group California's JNJ Position: Q2 2026 in Review

Legacy Capital Group California increased its Johnson & Johnson (JNJ) stake by 0.77% in Q2 2026, buying an estimated $10.7K and bringing the position to 6,006 shares worth $1.53M. The position accounts for 0.46% of the portfolio, ranked #52.

Legacy Capital Group California first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.29M in Q1 2025. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Legacy Capital Group California held 6,006 shares of Johnson & Johnson worth $1.53M as of Q2 2026.
  • Legacy Capital Group California bought 46 Johnson & Johnson shares in Q2 2026, an estimated $10.7K.
  • Johnson & Johnson made up 0.46% of Legacy Capital Group California's portfolio in Q2 2026, its #52 holding.
  • Legacy Capital Group California first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • Legacy Capital Group California's Johnson & Johnson position peaked at $2.29M in Q1 2025.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.